Company Filing History:
2 out of 15,475 
1 out of 1,381 
1 out of 103 Years Active: 1997-2012
Title: Edward Abraham: Innovator in Antibody Research
Introduction
Edward Abraham is a notable inventor based in Denver, Colorado. He has made significant contributions to the field of biomedical research, particularly in the development of antibodies and methods for treating various medical conditions. With a total of 4 patents, his work has had a substantial impact on the scientific community.
Latest Patents
Abraham's latest patents include groundbreaking research on antibodies that bind to urokinase-type plasminogen activator (uPA). These anti-uPA antibodies and their antigen-binding regions are designed to inhibit uPA-mediated inflammation. His work also describes methods for using these antibodies to activate uPA function, which can be crucial in treating inflammatory conditions. Another significant patent focuses on methods for treating hyperoxia, detailing the administration of specific compounds to alleviate conditions resulting from hyperoxia or mechanical ventilation.
Career Highlights
Throughout his career, Edward Abraham has worked with prestigious institutions such as the University of California and the University of Colorado. His research has been pivotal in advancing our understanding of antibody functions and their therapeutic applications.
Collaborations
Abraham has collaborated with notable colleagues, including Yi-Han Chang and Jack W. Singer, contributing to various research projects that enhance the field of antibody research.
Conclusion
Edward Abraham's innovative work in antibody research and treatment methods showcases his dedication to advancing medical science. His contributions continue to influence the development of new therapeutic strategies.